We then further analyzed the expression of UNC93B1 in AML and found that the level of UNC93B1 is significantly higher in FAB-M5 patients than any other FAB-subtype patient (p < 0.05, Figure 7A-B), which is consistent with the positive correlation expression of UNC93B1 and CD14, CD68 shown in Figure 5C. Here, UNC93B1 is linked to acute myeloid leukemia.